Is the antihypertensive effect of propranolol caused by an action within the central nervous system?
- PMID: 7452486
Is the antihypertensive effect of propranolol caused by an action within the central nervous system?
Abstract
Propranolol in doses from 0.01 to 5 mg/kg x day was infused intracerebroventricularly (i.c.v.) in conscious unrestrained spontaneously hypertensive rats during 5 days by using Alzet osmotic minipumps. When given by this route, brain concentrations achieve values that are approximately 100-fold higher than those after s.c. infusion of equal doses, whereas plasma-levels are comparable. In this study we compared the dose needed to lower blood pressure upon i.c.v. infusion with the dose of 5 mg/kg x day dl-propranolol, which we reported earlier to induce a long lasting bradycardia and antihypertensive effect when infused s.c. Vehicle, 0.01 and 0.1 mg/kg x day of dl-propranolol, did not have any effect on mean arterial pressure or heart rate. Infusion (i.c.v.) of 1 mg/kg x day lowered heart rate during the first 4 days of the infusion. On the fifth day, this effect had disappeared. Also, during the first 2 days of the infusion a reduction of mean arterial pressure was observed, but thereafter pressure was at control levels. Infusion of 5 mg/kg x day of dl-propranolol reduced heart rate significantly from the first day of infusion throughout the whole infusion-period. On the other hand, mean arterial pressure was lowered with a delay of 1 day. It remained significantly below control values throughout the rest of the experimental period. d-Propranolol in a dose of 5 mg/kg x day i.c.v. did not have any effects. Since upon i.c.v. infusion the dose needed for a blood pressure lowering effect is the same as that needed for a s.c. infusion, in spite of 100-fold higher brain-levels, it is concluded that the antihypertensive effect of propranolol in spontaneously hypertensive rats is not caused by an action of the drug in the central nervous system.
Similar articles
-
Steady-state disposition of propranolol and its total metabolites in the spontaneously hypertensive rat: chronic subcutaneous vs. intracerebroventricular infusion with osmotic minipumps.J Pharmacol Exp Ther. 1979 Jun;209(3):317-22. J Pharmacol Exp Ther. 1979. PMID: 439006
-
Possible role of an endogenous opioid in the antihypertensive action of propranolol in spontaneously hypertensive rats.Acta Physiol Hung. 1983;62(2):167-75. Acta Physiol Hung. 1983. PMID: 6670566
-
Differences in the acute and chronic antihypertensive mechanism of action of ketanserin in spontaneously hypertensive rats.J Pharmacol Exp Ther. 1993 Jan;264(1):129-34. J Pharmacol Exp Ther. 1993. PMID: 8093720
-
Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure.Biochem Soc Trans. 2000;28(4):435-40. Biochem Soc Trans. 2000. PMID: 10961935 Review.
-
Central hypotensive effect of propranolol.Postgrad Med J. 1976;52 Suppl 4:116-20. Postgrad Med J. 1976. PMID: 787951 Review.
Cited by
-
Rate-controlled drug dosage.Drugs. 1982 Mar;23(3):207-26. doi: 10.2165/00003495-198223030-00003. Drugs. 1982. PMID: 7042294 Review. No abstract available.